Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 148

Tests names and labsConditionsGenes and analytesMethods

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Center
Canada
3625
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MSH6 - Related Lynch Syndrome

Molecular Genetics Laboratory London Health Sciences Center
Canada
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

MSH2 - Related Lynch Syndrome

Molecular Genetics Laboratory London Health Sciences Center
Canada
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Familial Adenomatous Polyposis (FAP)

Ambry Genetics
United States
41
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel - High Penetrance 16

Molecular Genetics Laboratory London Health Sciences Center
Canada
2816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Colon and Endometrial Cancer-ColoNGS

GeneKor MSA
Greece
107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Familial Adenomatosis Polyposis

GeneKor MSA
Greece
52
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Lynch Syndrome

GeneKor MSA
Greece
75
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Colorectal Cancer NextGen Sequencing (NGS) And Deletion/Duplication Panel

PreventionGenetics
United States
2117
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

PMS1. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

MSH6. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

MSH2. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

MSH6. MLPA testing

Instituto de Medicina Genomica
Spain
31
  • D Deletion/duplication analysis

MLH1, MSH2. MLPA testing

Instituto de Medicina Genomica
Spain
32
  • D Deletion/duplication analysis

MLH1. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

PMS2. Complete sequencing

Instituto de Medicina Genomica
Spain
31
  • C Sequence analysis of the entire coding region

MLH1, MSH2, MSH6. NextGeneDx.Complete sequencing by NGS

Instituto de Medicina Genomica
Spain
53
  • C Sequence analysis of the entire coding region

Lynch Syndrome NextGen Sequencing (NGS) and Deletion/Duplication Panel

PreventionGenetics
United States
75
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome via the PMS2 Gene

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 148

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.